The IDH mutation status in the majority of GC patients could be correctly classified according to imaging phenotypes, but some IDH-wildtype glioblastomas with histological grade 2 or 3 (molecular glioblastomas) tended to exhibit imaging features indistinguishable from those of IDH-mutant astrocytomas. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).